1. Home
  2. CGEM vs SMR Comparison

CGEM vs SMR Comparison

Compare CGEM & SMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • SMR
  • Stock Information
  • Founded
  • CGEM 2016
  • SMR 2007
  • Country
  • CGEM United States
  • SMR United States
  • Employees
  • CGEM N/A
  • SMR N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • SMR Electrical Products
  • Sector
  • CGEM Health Care
  • SMR Industrials
  • Exchange
  • CGEM Nasdaq
  • SMR Nasdaq
  • Market Cap
  • CGEM 955.5M
  • SMR 960.6M
  • IPO Year
  • CGEM 2021
  • SMR N/A
  • Fundamental
  • Price
  • CGEM $15.79
  • SMR $24.97
  • Analyst Decision
  • CGEM Strong Buy
  • SMR Buy
  • Analyst Count
  • CGEM 7
  • SMR 5
  • Target Price
  • CGEM $31.67
  • SMR $11.50
  • AVG Volume (30 Days)
  • CGEM 439.6K
  • SMR 15.3M
  • Earning Date
  • CGEM 11-07-2024
  • SMR 11-07-2024
  • Dividend Yield
  • CGEM N/A
  • SMR N/A
  • EPS Growth
  • CGEM N/A
  • SMR N/A
  • EPS
  • CGEM N/A
  • SMR N/A
  • Revenue
  • CGEM N/A
  • SMR $7,381,000.00
  • Revenue This Year
  • CGEM N/A
  • SMR N/A
  • Revenue Next Year
  • CGEM N/A
  • SMR $181.20
  • P/E Ratio
  • CGEM N/A
  • SMR N/A
  • Revenue Growth
  • CGEM N/A
  • SMR N/A
  • 52 Week Low
  • CGEM $7.64
  • SMR $1.88
  • 52 Week High
  • CGEM $30.19
  • SMR $26.67
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 46.28
  • SMR 71.41
  • Support Level
  • CGEM $15.37
  • SMR $20.06
  • Resistance Level
  • CGEM $17.50
  • SMR $25.82
  • Average True Range (ATR)
  • CGEM 0.99
  • SMR 2.54
  • MACD
  • CGEM 0.05
  • SMR 0.25
  • Stochastic Oscillator
  • CGEM 27.35
  • SMR 81.57

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About SMR NuScale Power Corporation

NuScale Power Corp is engaged in the development of a new modular light water reactor nuclear power plant to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications.

Share on Social Networks: